Home » Topics » BioWorld Science

BioWorld Science
RSS

D-21266 demonstrates advantages over miltefosine in vivo

May 12, 1997

Glaxo obtains license to technology and porphyrin compound for dermatological diseases

May 12, 1997

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

May 9, 1997

Anti-HBV/anti-HIV L-nucleoside analogue described

May 9, 1997

New class of topo I inhibitors designed for oral administration

May 9, 1997

Natural cancer immunotherapeutic discovered by Yonsei University researchers

May 9, 1997

Novel EGF receptor TK inhibitor described by Mitsubishi

May 9, 1997

BM-92.0700: a promising anticancer clinical candidate

May 9, 1997

ONYX-015 demonstrates in vitro and in vivo efficacy

May 9, 1997

Preclinical data for ZD-1839, an EGF tyrosine kinase inhibitor

May 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...